Methods to measure treatment satisfaction in patients with pulmonary embolism or deep venous thrombosis

Current Opinion in Pulmonary Medicine

Volumn 16, Issue 5, 2010, Pages 437-441

  Essers, Brigitte A B ^a   Prins, Martin H ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

anticoagulant therapy; deep venous thrombosis; pulmonary embolism; treatment satisfaction

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; DEEP VEIN THROMBOSIS; DUKE ANTICOAGULATION SATISFACTION SCALE; FACTORIAL ANALYSIS; HUMAN; INTERNAL CONSISTENCY; LUNG EMBOLISM; PATIENT SATISFACTION; PERCEPTION OF ANTICOAGULATION TREATMENT QUESTIONNAIRE; PSYCHOMETRY; QUESTIONNAIRE; REVIEW;

ANTICOAGULANTS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PSYCHOMETRICS; PULMONARY EMBOLISM; VENOUS THROMBOSIS;

EID: 77955281429     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32833bde2b     Document Type: Review

References (34)

1. Bounameaux H, Perrier A. Duration of anticoagulation therapy for venous thromboembolism. Hematology Am Soc Hematol Educ Program 2008; 252-258.
2. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; the Mayo/FDA Patient-Reported Outcomes Consensus meeting Group. Value Health 2007; 10 (suppl 2):S66-S75.
3. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodological, and regulatory issues. Value Health 2004; 7:204-215.
4. Prins MH, Guillemin I, Gilet H, et al. Scoring and psychometric validation of the Perception of Antocoagulant Treatment Questionnaire (PACT-Q). Health Qual Life Outcomes 2009; 7:7-30.
5. Prins MH, Marrel A, Carita P, et al. Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health Qual Life Outcomes 2009; 6:7-9.
6. OShaughnessy D, Miles J, Wimperis J. UK patients with deep-vein thrombosis can be safely treated as out-patients. QJM 2000; 93:663-667.
7. Harrison L, McGinnis J, Crowther M, et al. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998; 158:2001-2003.
8. Le Sage S, McGee M, Emed JD. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients. J Vasc Nurs 2008; 26:109-117.
9. Kaczander BI, Cramblett JG, Mann GS. Perioperative management of the podiatric surgical patient. Clin Podiatr Med Surg 2007; 24:223-244.
10. Farag E, Dilger J, Brooks P, Tezlaff JE. Epidural analgesia improves early rehabilitation after total knee replacement. J Clin Anesth 2005; 17:281-285.
11. Chiou-Tan FY, Garza H, Chan KT, et al. Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury. Am J Phys Med Rehabil 2003; 82:678-685.
12. Noble SI, Finlay IG. Is long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative study. Palliat Med 2005; 19:197-201.
13. Hull JH, Hull PJ. Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer. N Engl J Med 2003; 349:1385-1387.
14. Blättler W, Gerlach HE. Implementation of outpatient treatment of deep-vein thrombosis in private practices in Germany. Eur J Vasc Endovasc Surg 2005; 30:319-324.
15. Ho SJ, Brighton TA. Ximelatragan: direct thrombin inhibitor. Vasc Health Risk Manag 2006; 2:49-58.
16. Ansell JE. Oral anticoagulants for the treatment of venous thromboembolism. Baillieres Clin Haematol 1998; 11:639-661.
17. Hauer KE. Low-molecular weight heparin in the treatment of deep venous thrombosis. West J Med 1998; 169:240-244.
18. Garwood CL, Dumo P, Baringhaus SN, Laban KM. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy 2008; 28:20-26.
19. Matsagas MI. Outpatient treatment of venous thromboembolism using low molecular weight heparins. An overview. Int Angiol 2004; 23:305-316.
20. Ansell J. New anticoagulants and their potential impact on the treatment of thromboembolic disease. Curr Hematol Rep 2004; 3:357-362.
21. Booth K, Clegg A, Sands G. Achieving home-based care for deep vein thrombosis. Community Nurse 1999; 5:23-24.
22. Wieland KA, Ewy GA, Wise M. Quality assessment and improvement in a university-based anticoagulation management service. Pharm Pract Manag Q 1998; 18:56-78.
23. Hull RD, Pineo GF, Brant R, et al. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and postthrombotic syndrome. Am J Med 2009; 122:762-769.
24. Hedner E, Carlsson J, Kulich KR, Stigendal L, Ingelgård A, Wiklund I. An instrument for measuring health-related quality of life in patients with Deep Venous Thrombosis (DVT): development and validation of Deep Venous Thrombosis Quality of Life (DVTQOL) questionnaire. Health Qual Life Outcomes 2004; 2:30.
25. Samsa G, Matchar DB, Dolor RJ, et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual Life Outcomes 2004; 2:22.
26. Bishop B, Wilson AG, Post D, et al. A pilot study of home treatment of deep vein thrombosis with subcutaneous once-daily enoxaparin plus warfarin. J Manag Care Pharm 2006; 12:70-75.
27. Shiach CR, Campbell B, Poller L, et al. Reliability of point-of-care prothrombin time testing in a community clinic: a randomized crossover comparison with hospital laboratory testing. Br J Haematol 2002; 119:370-375.
28. Goldhaber SZ, Morrison RB, Diran LL, et al. Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. Arch Intern Med 1998; 158:2325-2328.
29. Woods K, Douketis JD, Schnurr T, et al. Patient preferences for capillary vs venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res 2004; 114:161-165.
30. Rodger MA, Gagné-Rodger C, Howley HE, et al. The outpatient treatment of deep venous thrombosis delivers cost savings to patients and their families compared to inpatient therapy. Thromb Res 2003; 112:13-18.
31. Smith BJ, Weekley JS, Pilotto L, et al. Cost comparison of at-home treatment of deep venous thrombosis with low molecular weight heparin to inpatient treatment with unfractionated heparin. Intern Med 2002; 32:29-34.
32. Zed PJ, Filiatrault L, Busser JR. Outpatient treatment of venous thromboembolic disease based in an emergency department. Am J Health Syst Pharm 2005; 62:616-619.
33. Pout G, Wimperis J, Dilks G. Nurse-led outpatient treatment of deep vein thrombosis. Nurs Stand 1999; 13:39-41.
34. Lenderking WR. Brief reflections on treatment satisfaction. Value Health 2005; 8:S2-S5.